DANA™ is an FDA cleared suite of cognitive and psychological assessments that measures subtle and acute changes in cognitive resilience and speed to aid in the assessment of an individual’s medical or psychological state.

It provides a wealth of data – from single glance top level scores to intensively detailed trial by trial data – and gives an over-time, visual representation of a person’s cognitive development side-by-side with psychological test scores. 

DANA has exceptional sensitivity, reproducibility, and controls for training and practice effects. It is HIPAA compliant and available for both Android and iOS devices. DANA is also reimbursable by federal and commercial payers for medically necessary instances that are ordered by a qualified healthcare professional.